Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer

BACKGROUND: Advances in the treatment of metastatic colorectal cancer (mCRC) in the last decade have significantly improved survival; however, simple biomarkers to predict response or toxicity have not been identified, which are applicable to all community oncology settings worldwide. The use of inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Chua, W, Charles, K A, Baracos, V E, Clarke, S J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078587/
https://www.ncbi.nlm.nih.gov/pubmed/21448173
http://dx.doi.org/10.1038/bjc.2011.100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078587/
https://www.ncbi.nlm.nih.gov/pubmed/21448173
http://dx.doi.org/10.1038/bjc.2011.100

Ejemplares similares